Covovax to be approved as Covid-19 booster in 10-15 days: Adar Poonawalla

Serum Institute of India (SII)’s Covovax vaccine which is effective against the omicron strains will get approval as a booster jab against Covid-19 in the next 10 to 15 days. 

SII's Chief Executive Officer Adar Poonawalla said, “Covovax will be approved as a booster in the next 10-15 days. It is actually the best booster because it works very well against Omicron, more than Covishield.”

He said that everyone was looking at India, not just in terms of healthcare but because the country managed to take care of a huge and diverse population and also helped 70 to 80 nations during the Covid-19 pandemic.